Clinical Trials Arena Weekly Update 03.11.2023
Clinical Trials Arena
The leading site for data driven news in the Clinical Trial industry. Part of GlobalData.
Here is your weekly round up of the biggest news, stories and analysis in the Clinical Trials Industry.
AI in biotech: Still in search of desired talent and filling the regulatory gap
In our latest feature we look at how mainstream popularity is driving the acceptance of AI, yet lack of talent, regulatory uncertainty, and unknown impact may be halting the adoption. Read More
Strained relationships between CROs and sponsors in the spotlight at OCT Nordics 2023
The 11th Annual Outsourcing in Clinical Trials Nordics conference in Copenhagen shone a spotlight on the bureaucratic difficulties that can slow down clinical trials and lead to patient drop-out. Read More
Tibsovo unlocks new era for rare blood cancers called myelodysplastic syndromes
According to a GlobalData Healthcare epidemiology study, the number of five-year diagnosed prevalent cases of MDS in the US will reach 107,603 by 2028. Read More
US FDA grants IND clearance for ovarian cancer trial of Oncoinvent
The US Food and Drug Administration (FDA) has granted clearance for Oncoinvent ASA ’s investigational new drug (IND) application to commence the Phase II clinical trial of Radspherin to treat ovarian cancer associated peritoneal carcinomatosis. Read More
Rishi Sunak addresses existential AI threats ahead of UK safety summit
Rishi Sunak’s speech follows the release of a landmark AI report from the UK government highlighting serious threats posed by the emerging tech. Read More
LEO Pharma reports positive data from eczema therapy trial
The long-term safety profile of delgocitinib cream was in line with that recorded in prior data from DELTA 1 and 2 trials. Read More
AI skills can increase worker salary as much as 40%, says study
Dr. Fabian Stephany , research lecturer in AI at the Oxford Internet Institute, University of Oxford , says he is doubtful that AI would entirely replace the human workforce. - Read More
Recommended by LinkedIn
Merck’s Keytruda trial achieves secondary endpoint of OS
Keytruda showed a statistically significant and clinically meaningful improvement in OS against placebo. Read More
Partner Content
How electronic clinical outcome assessments improve clinical trial evidence generation
With clinical research sponsors collecting an increasing amount of clinical data, it is vital that outcomes measures collected are reliable and can support accurate decision making. We spoke to Bill Byrom Vice President of Product Intelligence and Positioning, and Principal eCOA Science at Signant Health about how electronic methods of capturing data can help? Read More
Will mobile visits help the clinical trials industry meet its diversity goals?
Lowering barriers to participation could boost the diversity of patients in clinical trials. We analyze gender, race and ethnicity data and speak with Ellen Weiss, vice-president of In-home Solutions at mobile research company PCM TRIALS - Quality Mobile Research to understand the differences that mobile visits from a certified mobile research nurse can make. Read More
Contact Us
For Editorial Enquires - clinicaltrialsarena@globaldata.com
For Advertising & Content Marketing Enquires - josh.jones@globaldata.com